| abstract |
Disclosed are methods of treating atherosclerosis and related conditions using compounds of Formula I, and pharmaceutically acceptable salts and solvates. These compounds are useful for the treatment of dyslipidemia, particularly for lowering serum LDL, VLDL and triglycerides, and increasing HDL levels. |